Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland

Summary

This observational study intends to evaluate the use and adherence of different types of primary care practices to the diabetes criteria-protocol (diabetes score), developed by the Swiss Society of Endocrinology and Diabetology. This diabetes score comprises visits to the doctor, lifestyle consultations, clinical measures such as blood pressure, cholesterol or blood sugar, as well as measures concerning the prevention of secondary complications like kidney, eye or feet issues. The participating primary care practices need to treat 80% of their diabetes patients (their "diabetes population") in accordance to the score-criteria. In addition to the adherence to the eight score-criteria, the practices are required to also document statistically if their diabetes patients get the following medication: oral antidiabetics, insulin, blood pressure medication, statins and / flu vaccine. As this observational study is and before-and-after study, the primary care practices need to document for each of their diabetes patients the care they provided in the year before the introduction of the score-criteria and in the year following their introduction. Participating primary care practices ask their diabetes patients' consent to the documentation and anonymous transmittance of their data. Data evaluation is anonymous and on a population-based level (as opposed to individual-based). The hypothesis of the study is to prove that the implementation of evidence-based measures, such as a diabetes score can increase the treatment quality of diabetes patients in primary care practices and this increase is independent of the primary care practice structure in which it is applied.

Conditions

• Diabetes Mellitus, Type 2
• Primary Care

Interventions

PROCEDURE

Best Practice Diabetes Management in Primary Care

Practice adherence to best practice guidelines treating diabetes patients in different primary care practices is shown in this before- and after observational study

Sponsors & Collaborators

• Swiss Society of Endocrinology and Diabetology

  collaborator UNKNOWN

• Roche Diabetes Care

  collaborator INDUSTRY

• Sanofi

  collaborator INDUSTRY

• Concordia Versicherungen AG

  collaborator UNKNOWN

• Novo Nordisk A/S

  collaborator INDUSTRY

• Galenica

  collaborator UNKNOWN

• QualiCCare

  lead OTHER

Principal Investigators

• Emanuel Christ, Prof. · University Hospital, Basel, Switzerland

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-01-01

Primary Completion

2019-06-01

Completion

2020-12-31

Countries

• Switzerland

Study Locations